208 Chapter 5 Table S1: Codebook of final themes (Continued) Main code Subcode Description Quotations Collection methods Related to the logistics of how CCP is collected and the challenges encountered and subsequent improvisation therein. “There are 16 plasma collection centers in the country, but with the 1.5 m separation, capacity diminished. So a task force led the way to look at [improving] logistics. There were some problems. At this point, the hyper IgG project had begun so they too needed more plasma, but it needed to be separated from the other collection. Also at this point, the RCT at Erasmus was still undergoing and the plasma collected for them needed to have separate logistics for separate antibody testing with extra tubes. While this was a small sample of the overall collection, it was a hassle to separately collect, store, and hand-collect from inventory etc.” (Respondent 1) Product characteristics Related to the differentiation of CCP from other plasma products and subsequent improvisation therein. “But it is a convalescent plasma, that’s the only difference. So it has to do with precounts by the donor to establish if the donor is the right donor to donate his blood or her blood. That’s the main difference. And you have to keep it separate from all the other plasma so that you know i) this is a convalescent plasma, and ii) this is standard plasma. So that is to keep in mind.” (Respondent 6) Testing Related to the challenges of antibody testing, its logistics and subsequent improvisation therein. “We were very busy develop[ing] tests for the antibody testing. And it was very difficult to find suitable tests because we wanted the right antibodies in our product. I don’t know if you’re familiar with it, but it’s just IgG and IgM and the neutralizing antibodies. But now with the neutralizing antibodies, that’s the antibody we want in our product. But you have to have a test to find these, and not all tests are suitable to find these antibodies.” (Respondent 3)
RkJQdWJsaXNoZXIy MTk4NDMw